Suncoast Ventures Company Profile
Background
Overview
Suncoast Ventures is a venture capital firm established in July 2021, headquartered in San Diego, California. The firm is dedicated to fostering innovation in the healthcare sector by providing mentorship and support to early-stage companies. Suncoast Ventures focuses on addressing critical healthcare challenges through strategic investments and partnerships.
Mission and Vision
The firm's mission is to equip, enable, and empower global health innovation and impact. Suncoast Ventures aims to create a better world by leveraging its expertise, networks, and unwavering belief in a better future. The firm emphasizes high performance and impact, striving to address significant market gaps in the healthcare industry.
Primary Area of Focus
Suncoast Ventures specializes in early-stage healthcare startups, particularly in areas such as digital health, diagnostics, med-tech, machine learning, artificial intelligence, and biotechnology. The firm provides ongoing mentorship and support to its portfolio companies, fostering their growth and development.
Industry Significance
By focusing on healthcare innovation, Suncoast Ventures plays a pivotal role in addressing critical healthcare challenges. The firm's commitment to diversity and inclusion, exemplified by its education program and loan fund for high-performing women-led companies, further enhances its impact in the industry.
Key Strategic Focus
Core Objectives
Suncoast Ventures aims to back resilient entrepreneurs who are creating innovation for critical healthcare gaps. The firm seeks to address significant market needs by investing in companies that offer innovative solutions in the healthcare sector.
Specific Areas of Specialization
The firm's investment focus includes:
- Digital health
- Diagnostics
- Med-tech
- Machine learning
- Artificial intelligence
- Biotechnology
Key Technologies Utilized
Suncoast Ventures leverages its expertise in various technologies to identify and support innovative healthcare solutions. The firm's focus on machine learning and artificial intelligence enables it to assess and invest in cutting-edge healthcare technologies.
Primary Markets or Conditions Targeted
The firm targets early-stage healthcare startups that address critical market needs, aiming to foster innovation and growth in the healthcare sector.
Financials and Funding
Funding History
Suncoast Ventures has been actively investing in early-stage healthcare companies since its inception in 2021. The firm has participated in several funding rounds, including seed and pre-seed investments.
Total Funds Raised
Specific details regarding the total funds raised by Suncoast Ventures are not publicly disclosed.
Recent Funding Rounds
Recent investments by Suncoast Ventures include:
- June 28, 2025: Seed round investment in Aware Health.
- April 17, 2025: Pre-seed round investment in Trellis Health.
- August 29, 2024: Seed round investment in Aware Health.
- July 26, 2024: Seed round investment in Sober Sidekick.
Notable Investors
Specific details about individual investors are not publicly disclosed.
Intended Utilization of Capital
The capital raised is utilized to support early-stage healthcare startups, providing them with the necessary resources to develop and scale their innovative solutions. This includes funding for product development, market expansion, and operational growth.
Pipeline Development
Key Pipeline Candidates
Suncoast Ventures has invested in several promising healthcare startups, including:
- Aware Health: A digital platform offering same-day teleconsultation services for musculoskeletal care.
- Trellis Health: A healthcare application focused on supporting women during pregnancy.
- Sober Sidekick: A mobile application and telehealth platform designed to support individuals in maintaining their sobriety.
Stages of Clinical Trials or Product Development
Specific details regarding the stages of clinical trials or product development for these companies are not publicly disclosed.
Target Conditions
The target conditions addressed by these startups include musculoskeletal issues, pregnancy-related health concerns, and addiction recovery.
Relevant Timelines for Anticipated Milestones
Specific timelines for anticipated milestones are not publicly disclosed.
Technological Platform and Innovation
Proprietary Technologies
Suncoast Ventures leverages proprietary technologies, including its AI-driven platform, PlanFoundry, to validate and support the development of new ventures.
Significant Scientific Methods
The firm employs rigorous market research and founder placement strategies to ensure the success of its portfolio companies. This includes integrating AI-driven validation and providing comprehensive operational, strategic, and financial support.
AI-Driven Capabilities
Suncoast Ventures utilizes AI-driven capabilities to validate business ideas and support the development of scalable systems for its portfolio companies. This approach enables the firm to systematically launch profitable companies from scratch.
Leadership Team
Genevieve LeMarchal – Managing Partner
Genevieve LeMarchal is the Managing Partner of Suncoast Ventures. She previously served as Partner at a science-focused advisory and fund in formation, was a General Partner at Oregon-based FoundersPad VC Fund II, and is a co-founder of the XXcelerate Fund. She holds an MBA in Finance from the Foster School of Business, University of Washington, and a B.A. in Communication from Washington State University.
Charla Triplett – Senior Venture Partner
Charla Triplett has over 20 years of experience bridging the gap between academia, business, startups, non-profit, and venture capital. She is a Senior Venture Partner at Expert Dojo and CEO of Spine by Design. She holds an M.S. in Bioengineering from Oregon State University and a B.S. in Microbiology from Washington State University.
Hal Walbrink – Venture Partner
Hal Walbrink is the Founder/CEO of Xinetix Medical Product Development and Venture Partner at Suncoast Ventures. He has served 40+ years in roles ranging from Board Chairman to CXO, advisor, investor, and technical expert to over 100 companies. He holds a BASc in Electrical Engineering from Cal State Fullerton and has studied Microprocessor Systems Engineering at UC Irvine.
Ray Costantini – Venture Partner
Ray Costantini is the Founder and CEO of Bright.MD. He has more than 20 years of experience as an executive physician leader turned entrepreneur. He holds an MD from the University of Arizona College of Medicine and an MBA from the Thunderbird School of Global Management.
Tammy Mahaney – Venture Partner
Tammy Mahaney is a former Army Captain and Doctor of Nurse Practice. She has 20 years of nursing experience and has served in clinical settings in Nicaragua, Tanzania, Vanuatu, El Salvador, and Ecuador. She holds a DNP-FNP from the Medical University of South Carolina and a BSN from Syracuse University.
Russ Nash – Venture Partner
Russ Nash is an investor, Board Director, and Advisor to several emerging, innovative companies in the health and technology segments. He previously served as Global Managing Director of Accenture's Health Industry Group and Managing Director of the U.S. Health Payer Client Group. He holds a B.S. in Applied Mathematics and Information Technology from the University of Connecticut.
Dr. Joe Geraci – Scientific Advisory – Artificial Intelligence, Machine Learning, Quantum
Dr. Joe Geraci is a mathematician, technologist, and quantum computations expert. He is the CEO of Netramark Corp and has a postdoc in oncology, neuropsychiatry, and medical ML. He holds a Ph.D. in Mathematical Physics from the University of Southern California and a Ph.D. in Applied Mathematics from the University of Toronto.
